UBS’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $42K | Buy |
3,652
+1,722
| +89% | +$19.8K | ﹤0.01% | 4791 |
|
|
2014
Q2 | $38K | Sell |
1,930
-29,460
| -94% | -$580K | ﹤0.01% | 4833 |
|
|
2014
Q1 | $563K | Buy |
31,390
+28,023
| +832% | +$503K | ﹤0.01% | 3081 |
|
|
2013
Q4 | $36K | Buy |
3,367
+1,583
| +89% | +$16.9K | ﹤0.01% | 4796 |
|
|
2013
Q3 | $22K | Sell |
1,784
-2,343
| -57% | -$28.9K | ﹤0.01% | 5006 |
|
|
2013
Q2 | $39K | Buy |
+4,127
| New | +$39K | ﹤0.01% | 4434 |
|